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A bstract 
Salmonella enterica serovar Typhimurium (STm) is an intracellular, gram-negative, 
facultative bacteria that causes two types of infection in humans: Typhoidal  and Non-
typhoidal Salmonella (NTS). NTS is known to cause a self-limiting gastroenteritis in the 
western world. However, it can be life-threatening to immunocompromised HIV-
infected and non-infected individuals living in Sub-Saharan Africa. This study aimed to 
characterise the impact of CD8 loss in the immune response to STm in the spleen, 
peritoneal cavity, and thymus though the use of a knock out mouse strain (CD8 KO) and 
the infection with an attenuated STm bacterial strain (SL3261). Predominantly, CD4+T-
cells or Th1 cells are more important in producing IFN-γ and mediating bacterial 
clearance during primary infection.  In contrast, the role of CD8 molecules during 
primary and secondary STm infection is less clear.  Bacterial culture revealed that 
bacterial clearance is hindered at day 35 post-infection in CD8 KO mice. We observed a 
defect in the early extrafollicular (EF) response with regards to the production of  lower 
levels of OMP-specific IgG at day 7 post-infection. This also inhibited isotype class-
switching; thus, IgG2b and IgG2a (IgG2c in C57BL/6 mice) antibody levels were also low. 
Thus, the absence of CD8 molecules must impact the early TFH response during thymus-
dependent (TD) antibody responses. In future experiments, it would be useful to 
characterise the immune response to STm in CD8 KO mice using a virulent strain of STm, 
SL1344 to see if primary infection with the attenuated strain allows for the conferred 
protection once challenged with the virulent strain.  
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A bbreviations 
AP  Alkaline phosphatase 
APC   Antigen Presenting Cell 
Bt  Biotin 
CD4  Cluster of Differentiation-4  
CD8   Cluster of Differentiation-8 
CFU  Colony Forming Units 
DAB  3,3´-diaminbenzidine tetrahydrochloride 
DC  Dendritic Cell 
DN  Double Negative 
EDTA  Ethylenediaminetetraacetic acid solution 
EF  Extrafollicular Response 
ELISA  Enzyme-Linked Immunosorbent Assay 
ELISpot Enzyme-Linked Immunosorbent Spot Assay 
FACS  Fluorescent Activated Cell Sorting 
FAE  Follicle Associated Epithelium 
FCS  Foetal Calf Serum  
HRP  Horse Radish Peroxidase 
Ig  Immunoglobulin 
I.P.  Intraperitoneal 
IFN-γ  Interferon-gamma 
IHC  Immunohistochemistry 
IL   Interleukin 
KO  Knock out 
LB  Luria Bertani 
LPS   Lipopolysaccharide 
MHC  Major Histocompatibility Complex 
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MLN  Mesenteric Lymph Node 
MZ  Marginal Zone 
NKT  Natural Killer T-Cells  
NOS  Nitric Oxide Synthase 
NTS  Non-Typhoidal Salmonella 
OD   Optical density 
OMPs  Outer Membrane Proteins 
PBS  Phosphate Buffered Solution 
pDCs  Plasmacytoid Dendritic Cells 
PEC  Peritoneal Cavity 
pNPP  p-Nitrophenylphosphate 
Px  Peroxidase 
RBCs  Red Blood Cells 
RP  Red pulp 
SCV  Salmonella-containing vacuole 
SP  Single Positive 
SP1-1  Salmonella Pathogenicity Island-1  
SP2   Salmonella Pathogenicity Island-2  
STm  Salmonella enterica serovar Typhimurium 
TCR  T-cell receptor 
TD  Thymus-dependent 
TFH   T-follicular helper cell 
Th1  T helper 1 cell 
TI   Thymus-independent 
TNF-α  Tumour Necrosis Factor- alpha 
WP  White pulp 
WT   Wild-type 
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Chapter 1: Introduction 
1.1 Salmonella enterica serovar Typhimurium 
Salmonella enterica serovar Typhimurium (STm) is an intracellular, gram-negative, 
facultative bacteria that causes two types of infection in humans: Typhoidal  and Non-
typhoidal salmonella (NTS).  
1.1.1 Non-typhoidal Salmonella (NTS) 
NTS is characterised by its self-limiting gastroenteritis in the western world. However, 
in Sub-Saharan Africa, NTS can be lethal to immunocompromised, HIV-infected 
individuals, including children who are not infected with HIV (Dougan et al., 2011).  
NTS causes a systemic, typhoid-like disease that involves the initial infection of  
intestinal Peyer’s patches and rapid dispersal to the blood, bone marrow, liver, spleen, 
and thymus (Moon and McSorley, 2009). Membranous (M) cells, which reside in the 
follicle-associated epithelium (FAE) just above the Peyer’s patches, and dendritic cells 
(DCs),  professional antigen presenting cells (APCs), induce the uptake of STm in the 
intestine and deliver them to resident macrophages below the FAE (Hughes and Galan, 
2002). 
1.1.2 STm Pathogenesis 
STm is a very robust bacterium. It can survive within APCs and replicate within 
phagocytes of the bone marrow, liver, spleen, and thymus. Furthermore, STm replicates 
within a modified endosome also known as the Salmonella-containing vacuole (SCV). 
Thus, STm manipulates the intracellular environment of the phagocyte through the 
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encouragement of optimal growth conditions via protein activity induced by the type III 
secretion system encoded by Salmonella pathogenicity island-2 (SP2) (Jackson et al., 
2010, Gog et al., 2012, Hensel, 2000, Santos et al., 2001, Griffin and McSorley, 2011, 
Mittrucker and Kaufmann, 2000). Furthermore, STm persist within phagocytes via the 
inhibition of phago-lysosomal fusion and acidification within the SCV (Dougan et al., 
2011). Typically, the environment of the phagocyte is characterised by poor nutrient 
availability, low pH, and constant exposure to antimicrobial peptides and enzymes (Luu 
et al., 2006). STm will rapidly infect and divide within the intracellular compartments of 
the vast population of macrophages (Jackson et al., 2010). Thus, STm can quickly 
overwhelm the host through the evasion of immune surveillance and bactericidal killing 
(Jackson et al., 2010).  
1.1.3 Animal Model of Salmonella infection 
The murine model of STm infection has been well-studied and is extensively used for the 
investigation of typhoid fever. Furthermore, the STm model of infection has similarities 
to human typhoidal infection caused by Salmonella enterica serovar Typhi (Moon and 
McSorley, 2009, Mittrucker et al., 2002).  
After a few days of initial infection, STm rapidly colonises the liver, spleen, and thymus 
and high bacterial loads persist until the host can limit bacterial growth. This period will 
normally last for a few-weeks until the host’s adaptive immune system sequesters 
bacterial replication and establishes a defence against reinfection (Mittrucker et al., 
2002).  Thus, CD4+T-cell and CD8+T-cell activation and the production of antibodies 
orchestrate an effective adaptive immune response that reduces and clears bacterial 
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infection within the host (Gil-Cruz et al., 2009, Cunningham et al., 2007, Mittrucker and 
Kaufmann, 2000, Mastroeni and Sheppard, 2004).  
Splenomegaly, an enlargement of the spleen, is a common hallmark of STm infection. It 
is initiated in the spleen and not from the peripheral circulation (Jackson et al., 2010, 
Mittrucker et al., 2002, Griffin and McSorley, 2011). Additionally, it occurs due to the 
vast recruitment and expansion of many activated cells such as T- and B- lymphocytes 
and phagocytes to the spleen (Mittrucker et al., 2002, Jackson et al., 2010). Splenic 
weight size is directly proportional to bacterial burden.  Thus, cellular recruitment and 
migration causes major disruptions to the splenic architecture and T-and B- cell zones 
lack definite structure. Thus, these factors collectively contribute to the ten-fold 
increases in splenic size (Cunningham et al., 2007, Jackson et al., 2010, Mittrucker et al., 
2002).  
In vivo models of STm infection, in particular with SL3261, an attenuated strain of STm, 
allows for the investigation of induction and resolution of bacterial infection, as well as 
the evaluation of bacterial and host interactions. Furthermore, genetic manipulations 
can be employed to the host (i.e. knockout mice (KO)) in order to assess requirements 
for innate and adaptive immune responses during the course of STm infection 
(Mastroeni et al., 2009, Santos et al., 2001). The bacterial burden of 108  STm within 
tissue  is considered to be the approximate threshold for mouse survival. Furthermore, 
as bacterial titres exceed this threshold, infected mice will succumb to bacteremia, 
endotoxic shock, and death (Mittrucker and Kaufmann, 2000). Typically, infection is 
established with 5 x 105 attenuated SL3261 in the Cunningham laboratory model of STm 
infection.  
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1.2 The Host and the Immune System 
1.2.1 Innate Immunity to STm 
Rapid dissemination of STm bacteria triggers the innate immune system to respond to 
the initial infection in order to monitor and reduce bacterial replication until the 
adaptive immune system mounts a response. Thus, innate immunity to STm requires 
complement mediated killing pathways in order to keep infection from overwhelming 
the host (MacLennan et al., 2008). Additionally, DCs, macrophages, neutrophils, and 
natural killer (NK) T-cells produce IFN-γ during the first few weeks of STm infection in 
order to limit bacterial growth (Jackson et al., 2010). STm bacterial growth is limited by 
macrophage migration inhibitory factor and Nramp1 (mice only), an innate resistance 
autosomal dominant gene, which resides on chromosome 1 and is expressed 
predominantly in macrophages (Mastroeni and Sheppard, 2004, Dougan et al., 2011).  
STm-infected macrophages can induce the production of reactive nitrogen and oxygen 
intermediates, as well as lysosomal enzymes that can severely pre-empt bacterial 
replication within the host (Griffin and McSorley, 2011).  
Initially, the innate immune response is established and chemokines recruit monophils 
and neutrophils to the site of STm colonisation where they induce nitric oxide (NO) 
synthase in order to kill STm bacteria (Jackson et al., 2010, Dougan et al., 2011).   
STm cell wall components of including lipopolysaccharide (LPS) and flagellin are known 
to induce an innate immune response via the production of Th1 (T-helper 1) cytokines 
such as IFN-γ, TNF-α (Tumour Necrosis Factor-α),  IL-6 (Interleukin 6) , IL-8, IL-12, and 
IL-18 (Dougan et al., 2011).  
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Although the innate immune response is effective at limiting bacterial replication in the 
host for the initial stages of STm infection, it does not completely eradicate STm from the 
immune system. Thus, the acquired immune response is needed to achieve sterile 
immunity in the host.  
1.2.2 Adaptive Immunity to STm 
1.2.2.1 Cell-mediated immunity 
STm rapidly infects and divides within host macrophages, yet triggers the production of 
IFN-γ by Th1 (T-helper 1) cells which inhibits bacterial growth (Moon and McSorley, 
2009, Jackson et al., 2010, Gog et al., 2012).  
1.2.2.1.1 CD4+T-cells 
Th1 or CD4+T-cells play an extremely important role in cell-mediated immunity. 
Additionally, TFH, T-follicular helper, cells are a particular subset of CD4+T-cells that are 
involved in driving T-cell responses and antigen-specific B-cell immunity i.e. the 
generation of memory B-cells and plasma cells. TFH cells express Bcl6, a master regulator 
transcription factor (Crotty, 2011). Bcl-6 expression is necessary for B-cell class 
switching (Lee et al., 2011). Furthermore, TFH cells help to form and maintain germinal 
centres (GCs), including the regulation of B-cell differentiation into memory B-cells and 
plasma cells (Crotty, 2011). TFH cells express cytokines such as IFN-γ and IL-17 that 
control isotype class-switching (Crotty, 2011).  Th1 and TFH cells play a key role in the 
immune response to STm and their differentiation pathways are depicted in Figure 1.1. 
Antigenic peptides presented by DCs activate naïve CD4+T-cells via a TCR (T-cell 
receptor) in the MHC-Class II pathway (Moon and McSorley, 2009). Once activated, these 
effector CD4+T-cells produce IFN-γ and TNF-α in response to MHC Class II recognition of 
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STm-infected phagocytes and presentation of antigenic peptides. Th1 cells are detected 
as early as one week into the infectious period and comprise more than 50% of all 
CD4+T-cells in circulation as early as two to three weeks into infection (Griffin and 
McSorley, 2011) 
 
FIGURE 1.1 . A CLASSICAL VIEW OF HELPER CD4+T-CELL DIFFERENTIATION. PICTURE SHOWS A DC 
PRIMING A NAÏVE CD4 +T-CELL, EFFECTOR SUBSETS, AS WELL AS CYTOKINE SECRETION. PICTURE 
TAKEN FROM (O'SHEA AND PAUL, 2010).  
 
1.2.2.1.2 CD8+T-cells 
STm also triggers the activation and dissemination of CD8+T-cells (Jackson et al., 2010). 
However, the role of CD8+T-cells in STm infection is poorly characterised and less 
understood (Moon and McSorley, 2009).  
Furthermore, there have been conflicting studies using a virulent strain of STm 
(SL1344) that have suggested that CD8+T-cells are important for clearing bacterial 
infection in primary infection (Luu et al., 2006, Lo et al., 1999, van der Velden et al., 
2005), whilst other studies using an attenuated strain of STm (SL3261) have suggested 
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only a minor role for reducing bacterial numbers in primary infection (Lee et al., 2012, 
Hess et al., 1996, Mastroeni et al., 1992).  
More interestingly, infection with ST-YopE-Ova (recombinant STm that incorporates 
ovalbumin (OVA) into a plasmid that codes for a Yersinia outer-membrane protein E 
(YopE)) suggests that once CD8+T-cells are made to recognise STm antigens, they are 
considered extremely important in mediating immune surveillance in primary infection 
(Tzelepis et al., 2012). Furthermore , adoptive transfer experiments have shown that 
CD8+T-cells play a role in the acquired immunity to STm infection (Nauciel, 1990). 
1.2.2.2 Humoral immunity  
Antibody (Ab) or humoral immunity is required for protective immunity against 
secondary infection (Moon and McSorley, 2009). B-cells and subsequently, the 
production of antibodies, are not required for the resolution of primary STm infection; 
however, they are required for an acquired immune response once challenged at a later 
time (Griffin and McSorley, 2011).  Antibody can have direct access to STm in the 
extracellular compartment once infected phagocytes have undergone apoptosis. Thus, 
the antibody opsonizes the extracellular STm and prevents it from infecting an adjacent 
phagocyte (Cunningham et al., 2007, Griffin and McSorley, 2011).  
1.2.3 Sites of STm colonisation 
1.2.3.1 The Spleen 
The spleen is a secondary lymphoid organ that is located in the abdominal cavity and 
connected to the stomach (Mebius and Kraal, 2005). It  collects antigens from the blood, 
as well as the collection and disposal of old erythrocytes (Janeway et al., 2005). The 
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spleen is composed of red pulp and white pulp, which is divided by the marginal sinus 
(Figure 1.1)(Vale and Schroeder, 2010).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 1.2. Structure of the spleen, which includes the clearly defined regions of red pulp, 
white pulp, MZ, T-cell zones, as well as B-cell follicles. Adapted from Mebius and Kraal (2005).  
 
1.2.3.1.1 Red Pulp 
 The red pulp is the main location for erythrocyte disposal (Janeway et al., 2005). 
Macrophages, a type of APC, are found within the red pulp and are intrinsic in the 
removal of bacteria from the blood. Signalling cascades via toll-like receptors (TLRs) 
begin once macrophages have encountered bacteria and they secrete molecules that 
inhibit the growth of bacteria (Mebius and Kraal, 2005). Plasmablasts and plasma cells 
are also located within the red pulp. Plasmablasts are activated B-cells that have not 
differentiated into mature plasma cells (Mebius and Kraal, 2005). Initially, they 
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differentiate in the follicles of the white pulp and then migrate to the red pulp. After 
subsequent migration to the red pulp, they migrate through the lymph and blood to 
travel to sites where they will mature into antibody-producing plasma cell factories 
(Mebius and Kraal, 2005) 
 
1.2.3.1.2 White Pulp 
The white pulp regions are composed of lymphocytes that surround the arterioles of the 
spleen (Janeway et al., 2005). Furthermore, these areas contain clearly defined B-cell 
follicles and a T-cell zone (Mebius and Kraal, 2005).  
1.2.3.1.2.1 B-Cell Follicles 
B-cells form follicles, which are sites of clonal expansion for activated B-cells (Mebius 
and Kraal, 2005). T-cells, previously primed by DCs in the T-zone, subsequently prime B-
cells within the T-zone (Section 1.2.3.1.2.2). Activated follicular B-cells will go on to 
proliferate and form GCs or differentiate into plasmablasts. They can also differentiate 
into non-proliferating plasma cells, which also secrete antibody (MacLennan et al., 
2003) . These events are part of the extrafollicular response (EF) (Figure 1.3) , which is 
responsible for the rapid generation of antibodies following a pathogen encounter 
(MacLennan et al., 2003). An EF response can also trigger antibody class-switching and 
somatic hypermutation, which is defined as introducing variation into the variable 
region of immunoglobulin for positive and negative selection of antigen-binding sites 
(Janeway et. al, 2005).  
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Figure 1.3. The Extrafollicular Antibody Response (EF). Picture taken from MacLennan et al. 
(2003). 
 
1.2.3.1.2.2 T-Cell Zone 
T-cell zones consist of T-cells that display interactions with B-cells and DCs (Mebius and 
Kraal, 2005). Once APCs enter the white pulp, activated T-cells migrate to B-cell follicles 
and activate B-cells. Once activated, B-cells will class-switch and then migrate to the GCs, 
MZ, or red pulp (Mebius and Kraal, 2005). This is an example of  T-dependent activation 
of B-cells.  
1.2.3.1.2.3 Marginal Zone 
The marginal zone (MZ) is another important cell-transit region that surrounds the 
white pulp (Mebius and Kraal, 2005). It is characterised as a highly organized region 
composed of a large population of macrophages and a select population of B-cells, also 
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known as MZ B-cells and a small population of follicular dendritic cells (FDCs) (Janeway 
et al., 2005). The macrophages trap blood-borne pathogens in the MZ (Janeway et al., 
2005). The MZ B-cells act quickly to inhibit pathogen invasion by acting as APCs or 
differentiating into plasma cells that produce IgM (Mebius and Kraal, 2005). MZ  B-cells 
express the phenotype of IgMhi, CD1dhi, CD9hi, CD21hi, CD22hi, IgDlo,CD23lo, and 
B220lo. Activated MZ B-cells can act as APCs by obtaining antigenic peptides within the 
MZ and migrating into the white pulp where they can activate naïve CD4+T-cells (Mebius 
and Kraal, 2005).  FDCs may possess long processes like DCs; however, they are 
distinctly different from other types of DCs because they are not phagocytic and do not 
derive from bone marrow precursors (Janeway et al., 2005). Furthermore, FDCs do not 
express MHC-Class II on their cell surfaces (Janeway et al., 2005). FDCs are derived from 
mesenchymal stem cells and display receptors for complement and Fc  (Banchereau and 
Steinman, 1998). FDCs are entirely distinct from other types of DCs because they do not 
process the antigen (Vale and Schroeder, 2010). Instead, FDCs are responsible for 
presenting antigen in the form of immune complexes to activate B-cells within the B-cell 
follicle (Vale and Schroeder, 2010).  In turn, these follicular B-cells become activated and 
differentiate and play a major role in the adaptive immune response (Vale and 
Schroeder, 2010).  
1.2.3.1.2.3.1 T-independent response 
B-cells can respond via direct contact with an antigen in contrast to T-cells, which 
require an APC to become activated (Vale and Schroeder, 2010). Once a B-cell is 
activated, it can divide and differentiate into memory cells or activated plasma cells that 
become antibody factories.  
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1.2.3.1.2.3.2 T-dependent response 
MHC Class I and II molecules are both present on activated B-cells. Thus, B-cells can 
engulf and present an antigenic peptide to CD4+T-cells and CD8+T-cells (Vale and 
Schroeder, 2010). B and T-cells can actively co-stimulate each other once they bind the 
same antigenic peptide, which enhances the adaptive immune response if challenged 
with the same pathogen in the future (Vale and Schroeder, 2010).  
GCs  also play a large role in the humoral or B-cell mediated response to an infection. 
GCs form in the white pulp as a result of the interaction and subsequent activation 
between T-cells and B-cells within the first 3 weeks of antigenic exposure (Vale and 
Schroeder, 2010, MacLennan, 1994). Additionally, affinity maturation, somatic 
hypermutation, and antibody class switching occur within a GC (MacLennan, 1994). 
Affinity maturation is defined as the selection and subsequent survival of B-cells with 
high affinity for a particular antigen (Janeway et al., 2005).  Antibody or isotype class 
switching is the selection of B-cells to differentiate into effector cells that promote the 
secretion of antibodies with different isotypes (Janeway et al., 2005).  
1.2.3.2 The Peritoneal Cavity  
The peritoneal cavity provides a niche for B1b cells, which are self-renewing and have 
unique activation properties and cell cycles that differ markedly from B2 cells that 
reside in the spleen and lymph nodes (Martin and Kearney, 2002). Furthermore, PEC 
(peritoneal cavity) cells are known to share some properties to MZ B-cells (Martin and 
Kearney, 2002). Additionally, B1b cells are precursors to cells that secrete IgM (Martin 
and Kearney, 2002). B1a and B1b cells express the surface marker phenotype IgM+, 
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IgDlowCD21lowCD23lowB220intCD19+ and CD11b variable (Marshall et al., 2012).  B1b cells 
are intrinsic for mounting a protective antibody response to pathogens (Marshall et al., 
2012).  
1.2.3.3 The Thymus 
The thymus, located in the upper anterior thorax, is composed of two lobes, which each 
consist of an outer cortical region and an inner medulla (Janeway et al., 2005). The 
thymus is the site for differentiation of T-cells (Nunes-Alves et al., 2013). T-cell 
differentiation (Fig. 1.4) depends on the type of antigen that thymocytes encounter, as 
well as the surrounding thymic architecture and environment (Nunes-Alves et al., 2013). 
 
Figure 1.4. T-cell differentiation and positive and negative selection in the thymus. Image 
taken from Germain (2002).  
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1.2.3.3.1 Thymic Cortex 
The thymic cortex consists of an outer region that is comprised of proliferating 
immature thymocytes and a deeper region that consists of immature T-cells undergoing 
positive or negative thymic selection (Fig. 1.4) , which pre-empts the proliferation of 
self-reactive T-cells (Nunes-Alves et al., 2013)(Janeway et al., 2005). Thymocytes are 
derived from double-negative (DN) CD4 and CD8 cells and mature to CD4 single-positive 
(SP) or CD8 single positive (SP) via CD4 and CD8 double positive intermediates (Ross et 
al., 2012). Positive selection is defined as the maturation of immature thymocytes into 
CD4+T-cells and CD8+T-cells induced by T-cell receptor (TCR) signals that result from 
binding to MHC Class II or I ligands, respectively (Germain, 2002). Negative selection is 
defined as thymocyte cell loss via apoptosis within the thymus due to an overwhelming 
T-cell signalling response(Germain, 2002). Additionally, the cortex consists of branched 
cortical epithelial cells and dispersed macrophages (Janeway et al., 2005).  
1.2.3.3.2 Thymic Medulla 
The inner medulla is comprised of medullary epithelial cells, mature thymocytes, 
macrophages, and dendritic cells (Janeway et al., 2005). T-lymphocytes or T-cells derive 
from a common lymphoid progenitor in the bone marrow that migrate and commit to 
development within the thymus (Janeway et al, 2005).  
1.2.3.3.3 Thymic atrophy is induced as a result of STm infection 
Infection can affect the thymus locally and systemically (Nunes-Alves et al., 2013). 
Additionally, thymic atrophy occurs as a direct result of STm infection. It is characterised 
by a steady decrease in the number of thymocytes (Nunes-Alves et al., 2013). However, 
the reasons for thymic atrophy are less understood. One hypothesis is that thymic 
atrophy is a mechanism of pathogen virulence, which shields the pathogen from the 
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immune response. Another hypothesis is that atrophy is simply a by-product of infection 
which does not possess a significant advantage to either the pathogen or the host. The 
last hypothesis is that the host induces thymic atrophy in order to reduce thymic output 
during infection in order to pre-empt the disruption of T-cell selection and central 
tolerance to the invading pathogen (Nunes-Alves et al., 2013). On the contrary, it was 
found that although thymic atrophy accompanies STm infection, thymic output is not 
reduced and CD4 +T-cell export is maintained (Ross et al., 2012). Furthermore, it is 
important to note that the number of thymocytes recovers in the thymus as the STm 
infection clears the host and atrophy is resolved (Ross et al., 2012). This particular study 
suggests that thymic atrophy and thymic output are entirely exclusive from one another 
(Nunes-Alves et al., 2013, Ross et al., 2012).  
1.3 CD8 Molecules in STm Infection 
CD8 (Cluster of Differentiation 8) molecules, also known as CD8 receptors, interact with 
Major Histocompatibility (MHC) Class I complexes. These complexes are defined as a 
collection of genes that encode membrane glycoproteins that subsequently present 
antigenic peptides to T-cells (Janeway et al., 2005).  The CD8 ligand binds to the MHC 
Class I molecule, which presents an antigenic peptide from an ingested intracellular 
pathogen. Subsequently, the CD8+T-cell or DC becomes fully activated.  
Initially, MHC-Class I obtains antigen fragments from the cytoplasm and presents them 
on the cell surface. Once activated, these cells begin to proliferate and can differentiate 
into cytotoxic T-cells (Tc) (Janeway et al., 2005).  MHC Class I molecules are present on 
nucleated cells in the immune system, whereas MHC Class II molecules are not. However, 
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MHC Class II molecules are overwhelmingly present on T-cells, B-cells, and DCs. 
Additionally, they present antigen to CD4+T-cells.  
1.3.1 CD8+T-cells 
T-cell mediated immunity is integral in clearing intracellular bacterial infection (Lo et al., 
1999).  CD4+T-cells are responsible for the recognition of exogenous antigens and are 
activated once pathogens have reached the vacuole of a cell (van der Velden et al., 2005). 
Conversely, CD8+T-cells are responsible for the recognition of antigens and pathogens 
that enter the cytoplasm (van der Velden et al., 2005). 
Previously, it has been shown that CD4+T-cells are more important than CD8+T-cells in 
acquired immunity to STm infection (Hughes and Galan, 2002). However, both CD4+T-
cells and CD8+T-cells are intrinsic in orchestrating anti-microbial resistance (Lo et al., 
1999). More specifically, CD8+T-cells are instrumental for the instruction of pathogenic 
and/or cancerous cells to kill themselves via apoptosis.   
Normally, CD8+T-cells are rapidly activated in infections caused by intracellular 
pathogens and are recruited as part of the adaptive immune response (Tzelepis et al., 
2012). However, in the case of virulent STm, which resides in macrophages, the 
activation of CD8+T-cells is delayed in primary infection (Tzelepis et al., 2012, Luu et al., 
2006, Mittrucker et al., 2002). 
The functionality of CD8+T-cells in the immune response is less clear and not well 
understood due to conflicting evidence from studies using different strains of STm. 
CD8+T-cells have been suggested to be important in secondary (not primary) protection 
in the resolution of STm infection. This investigation, using the attenuated SL3261 strain 
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of STm, shows that CD8+T-cells are important in both primary and secondary protection 
against STm.  
1.3.2 CD8 DCs 
Dendritic cells (DCs) are professional APCs on a majority of tissues that present antigens 
to naïve T-cells via MHC-Class I or II complexes in splenic T-zones (Banchereau and 
Steinman, 1998). They are key players in establishing bacterial immunity (Riquelme et 
al., 2012). However, STm can prevent DC-mediated activation of naïve T-cells and 
phagocytosis, thus preventing an adaptive immune response from occurring within the 
host (Riquelme et al., 2012).  
Furthermore, DCs stimulate B and T-cells. B-cells recognize antigens directly via their B-
cell receptor; however, T-cells need antigen presented to them via an APC, such as a DC 
(Banchereau and Steinman, 1998).  
In this study, we will investigate DCs in the thymus. Mature DCs in the mouse model 
express MHC-class II, the co-stimulatory molecules CD40, CD80, and CD86, as well as 
CD11c, an integrin α-x chain,  (Shortman and Liu, 2002). The T-cell markers, CD4 and 
CD8, are also present on mature DCs. Furthermore, CD8 or CD8α is an αα-homodimer, 
that is solely expressed on murine DCs and comprises about 70% of the thymus 
(Shortman and Liu, 2002). CD8+ DCs play an important role in antigen presentation and 
T-cell priming in the immune response to STm (Shortman and Liu, 2002).  
Three subsets of DCs have been found in the thymus (Li et al., 2009). They include: 
resident conventional DCs (cDCs), migratory cDCs, and plasmacytoid DCs (pDCs).  
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Plasmacytoid DCs (pDCs) (B220+CD11c+)  comprise  a subset of DCs that are responsible 
for producing IFN-γ, which plays an integral role in bacterial clearance during STm 
infection (Okada et al., 2003).  
CD103+ DCs (αΕ) comprise a population of DCs that are present on all lymphoid and non-
lymphoid organs (del Rio et al., 2010). It has been evidenced that twenty-three percent 
of STm reside within CD11c+CD11b- DCs (Voedisch et al., 2009). Furthermore, STm has 
been found to reside within CD103+ DCs and they have been associated with the uptake 
and presentation of STm in the mesenteric lymph node (MLN) of the gut (Voedisch et al., 
2009).  
1.4 Aims of the Study 
The aim of this study is to use a CD8 knock out mouse model to characterise how the 
immune system responds to systemic STm infection in context of CD8 loss. The 
following question will be assessed: 
1) How does STm infection impact the spleen, peritoneal cavity, and thymus in the 
absence of CD8 during the early (day 7) and later stages (day 35) of infection? 
a. What impact does CD8 loss have on the cellularity and architecture within 
each of these sites? 
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Chapter 2: Methods  
2.1 Materials  
Reagents and chemicals used in this study were obtained from Sigma-Aldrich (Poole, 
U.K.) unless stated otherwise.  
2.2 Animals Used 
Wild-type (WT) C57BL/6 mice were age and sex-matched between the ages of 6-12 
weeks old and were obtained from HO Harlan OLAC Ltd. (Bicester, U.K). Transgenic 
mice, B6.129S2-Cd8atm1Mak/J or CD8 Knock-Out (KO) mice (as referred to in text), were 
bred from colonies maintained in the University of Birmingham Biomedical Services 
Unit (BMSU). The reference and original source is listed in Table 2.1. All animals were 
housed in the BMSU in specific-pathogen free conditions.  
At specified times, mice were sacrificed by the Schedule 1 Method in compliance with 
United Kingdom (UK) Home Office (HO) guidelines. All experiments were carried out 
with ethical approval in accordance with the UK Ethics Committee.  
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Table 2.1: Knock-out mice used in the present study 
Mouse Strain  Phenotype/Description Original Source and Reference 
B6.129S2-Cd8atm1Mak/J 
(CD8 KO) 
This strain is deficient in 
functional cytotoxic T-cells 
Donated by Dr. Nick Jones 
 
University of Birmingham 
 
Originally purchased from 
Jackson Laboratories 
(Fung-Leung et al., 1991) 
 
2.3 Preparation of Antigens for Immunisation  
2.3.1 Bacterial Strains  
The attenuated Salmonella enterica serovar Typhimurium (STm) strain SL3261 is used 
throughout each infection (Hoiseth and Stocker, 1981).  
Table 2.2: Bacterial strains used in the present study 
Bacterial Strain Description Reference 
SL3261 
This strain is an attenuated 
auxotrophic mutant of 
Salmonella Typhimurium  
and is aro-A deficient. 
 
(Hoiseth and Stocker, 1981) 
   
 
2.3.1.1 Growth Conditions for SL3261 Bacterial Strain 
STm was incubated overnight  at 37°C with aeration (180 rpm) in sterile Luria-Bertani 
(LB) broth (recipe detailed in section 2.13) (Invitrogen, Paisley, UK) at and then diluted 
the next morning in LB broth and incubated as described but for 2 hours and grown 
until bacteria reached late-log phase (Optical Density (ODλ600 nm 0.9-1.0)).  
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Once the desired OD was reached, 1 mL of culture was transferred to an RNAse-free 
Eppendorf and harvested by centrifugation at 6,000 x g for 5 minutes at 4°C. Bacteria 
were washed twice in 1 mL sterile Phosphate Buffered Saline (PBS) at 6,000 x g for 5 
minutes at 4°C and then re-suspended in 1 mL sterile PBS. The ODλ600 nm was 
measured again and the bacteria were diluted to a concentration of 5 x 108 bacteria per 
mL. Mice were infected with 5 x 105 bacteria by intraperitoneal injection (i.p.) in a final 
volume of 200 µL. The actual dosage of bacteria administered was calculated using the 
Miles and Misra CFU counting technique (Miles et al., 1938). 
2.4 End-point of Infection 
At specific time points of STm infection, mice were anaesthetised and peripheral blood 
was obtained via cardiac puncture. Mice were then sacrificed by cervical dislocation. All 
organs were obtained and removed under aseptic technique. Cells were extracted and 
isolated from the peritoneal cavity (PEC) for flow cytometry. The spleen and thymus 
were also removed and weighed for flow cytometry (spleen only), bacterial culture, 
cytokine analysis by ELISA (Enzyme-Linked Immunosorbent Assay), ELISpot (Enzyme-
Linked Immunosorbent Spot Assay) , and immunohistochemistry (IHC).  
2.5 Bacterial culture  
The spleen and thymus (1 lobe per culture) were assessed for bacterial numbers after 
isolation. Tissues were weighed and then disaggregated in 1 mL of sterile RPMI-1640 
medium through a 70 µm cell strainer (BD Biosciences) and were diluted by 10-fold 
serial dilutions in sterile RPMI-1640 medium. Bacterial serial dilutions (100 µL) were 
plated onto LB agar plates (detailed in section 2.14) and incubated overnight at 37°C.  
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Bacterial colonies were counted the following day and the total CFU per spleen or 
thymus lobe was calculated from the mass of the tissue section and dilution used. 
2.6 Cell Preparation 
2.6.1 Splenocyte Preparation  
The spleen was disrupted in RPMI supplemented with 10% heat-inactivated foetal calf 
serum (FCS) and 1% penicillin/streptomycin (P/S) with subsequent disruption and 
filtration through a 70 µm cell strainer (BD Biosciences). Cells were then harvested and 
centrifuged at 175 x g for 4 minutes at 4°C.  Erythrocytes/red blood cells (RBCs) were 
then lysed in sterile ACK Lysing Buffer (Gibco Invitrogen Compounds) as per 
manufacturer’s guidelines. Cells were then washed in 5 mL of RPMI and centrifuged at 
175 x g for 4 minutes at 4°C to remove any residual lysis buffer. Cells were then re-
suspended in 10 mL RPMI  and viable cell numbers were counted in order to obtain 
viable cell numbers using Trypan Blue staining to quantify live cells. Samples were then 
diluted to obtain an optimum cell density of 1.0 x 107 cells per mL. 
2.6.2. Peritoneal Exudate Cells (PEC) Preparation 
PEC cells were removed from the peritoneal cavity in 5 mLs of FACS (Flourescence 
Activated Cell Sorter) buffer (PBS containing 10% FCS and 2mM EDTA 
(Ethylenediaminetetraacetic acid solution) (Fluka Analytical, UK). Cells were then 
washed at 175 x g for 4 minutes at 4°C.  If any samples contained RBCs, then they were 
lysed as per splenocytes. Cells were resuspended in 5 mL of FACS buffer and centrifuged 
at 175 x g for 4 minutes at 4°C to remove any residual lysis buffer and then re-
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suspended in 5 mLs of FACS buffer in order to determine cell density as described in 
section 2.6.1.  
2.7 Staining by Flow Cytometry 
Extracellular staining of splenocytes and PEC suspensions was carried out for 25 
minutes at 4°C in FACS buffer.  The antibodies that were used are described in Table 2.3. 
Diluted cell samples were harvested (1 x 106) in a V-bottom 96-well plate (Corning Life 
Sciences, Netherlands) and centrifuged at 175 x g for 4 minutes at 4°C. Pelleted cells 
were washed in FACS buffer at 175 x g for 4 minutes at 4°C.  Cells were then incubated 
with anti-CD16:CD32 antibody to block Fc receptors (CD32/FcγIII and CD16/FcγII 
receptors) prior to staining for 25 minutes at 4°C. Cells were then stained with the 
antibodies listed in Table 2.3. They were then washed with FACs buffer at 175 x g for 4 
minutes at 4°C and re-suspended in FACS buffer for acquisition on a Cyan FACS Analyser 
in conjunction with Summit  v4.3 software.  
Analysis of extracellular and intracellular stained single-cell suspensions were 
conducted offline by FlowJo software 9.6.3(TreeStar). 
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Table 2.3 Antibodies used for Flow Cytometry Staining  
Antibody Clone Dilution Source Target 
Purified 
CD16:CD32  
93 1:100 e-Bioscience Blocks  FcγII and 
FcγIII receptors 
CD3 FITC 145-2C11 1:100 e-Bioscience  
 
T-Cells 
 
 
CD4 Pacific Blue  1:100  
CD44 PerCP-Cy 
5.5 
IM7 1:200 e-Bioscience 
CD62L PE MEL-14 1:200 e-Bioscience 
CD19 APC -Cy7  ID3 1:200 BD Biosciences  
 
 
 
B-Cells/Spleen 
and PEC 
CD21 FITC 7G6 1:100 e-Biosciences 
CD23 PE B3B4 1:100 e-Biosciences 
B220 PE Texas 
Red 
RA3-6B2 
 
1:400 BD PharMingen 
CD5 PerCP Cy 5.5 53-7.3 1:200 e-Biosciences 
IgM PE- Cy7 11/41 1:200 e-Bioscience 
IgD Pacific Blue 11-26c 1:200 e-Bioscience 
CD11b  APC MI-70 1:200 e-Bioscience 
CD138 PE 281-2 1:300 BD PharMingen  
  Plasma Cells     
(Extracellular) 
B220 PerCP Cy 
5.5 
RA3-6B2 1:300 BD Bioscience 
CD19 APC 1D3 1:200 BD PharMingen 
IgG2b FITC Polyclonal 1:500 Southern Biotech 
IgG2b Isotype 
FITC 
N/A 1:500 BD PharMingen 
IgG2c FITC Polyclonal 1:1000 Southern Biotech 
IgG2c Isotype 
FITC 
RTK4174 1:1000 BioLegend 
CD69 FITC H1.2F3 1:200 e-Bioscience  
 
 
    Thymocytes 
  
CD4 Pacific Blue RM4-5 1:100 e-Bioscience 
CD44 PerCP-
Cy5.5 
IM7 1:200 e-Bioscience 
CD45 APC-Cy7 30-F11 1:500 e-Bioscience 
CD25 APC PC61.5 1:200 e-Bioscience 
TCR-β PE H57-597 1:200 e-Bioscience 
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2.8 Peripheral Blood 
Peripheral blood was obtained by cardiac puncture at sacrifice. Blood was left to clot for 
one hour at 37°C and serum was separated from the clotted blood via centrifugation at 
6000 x g for 15 minutes. Serum samples were then frozen and stored at -20°C until 
required for future ELISAs. 
2.8.1 Enzyme-Linked Immunosorbent Assay (ELISA) 
ELISA assays were performed against antigens including OMPs (outer membrane 
porins), purified porins, and LPS (lipopolysaccharide) (Alexis Biochemicals).  
OMPs were prepared and obtained from Charlotte Cook (University of Birmingham, UK) 
(Henderson et al, 1997).  Purified porins were obtained from Dr. Constantino López-
Macías (Mexico Institute for Social Security, Mexico City, Mexico) as described in Section 
2.3.2.  
Serological antibody titres were confirmed and quantified for specificity against the 
antigens mentioned above. Nunc Maxisorp flat-bottomed 96-well plates (Thermo Fisher 
Scientific) were coated with 5 µg/mL of the antigen of interest at 4°C overnight. The 
antigen was diluted in ELISA Carbonate Coating Buffer (0.83 g Na2HCO3, 1.42 g NaH2CO3, 
0.1% NaN3 in 500 mL of double-distilled H2O).  
After coating, plates were washed with ELISA wash buffer ( 0.05% Tween-20 (Sigma, 
UK) in 1x PBS). After washing, plates were blocked for 1 hour at 37°C in ELISA blocking 
buffer (1% Bovine Serum Albumin (BSA) (Sigma) in 1x PBS in 500 mL of double-distilled 
H2O). After blocking, plates were washed again in wash buffer and the primary 
antibodies (sera) were diluted in ELISA dilution buffer (0.05% Tween-20, 1% BSA in 
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500 mL of double-distilled H2O) initially at 1:10, 1:20, or 1:50 dilutions and in 
subsequent four-fold serial dilutions. Plates were incubated for 1 hour at 37°C and then 
washed  in wash buffer as before. Plates were then coated with alkaline phosphatase 
(AP)-conjugated antibodies (as described in Table 2.4) and incubated for 1 hour at 37°C. 
Plates were then washed for the last time in wash buffer and 100 µL of Sigma-Fast p-
Nitrophenylphosphate substrate (pNPP and TRIS tablets, Sigma N2770) was added to 
each well as per the manufacturer’s instructions. Plates were incubated with the 
substrate at 37°C until the desired colour change is obtained. Plates were read at λ405 
nm using Softmax Pro software on an Emax Precision Microplate Reader (Molecular 
Devices) and the antibody titres were obtained.   
Table 2.4 Antibodies used for ELISAs 
 
 
 
 
 
 
2.9 Cytokine ELISA  
Cytokines (IFN-γ and TNF-α) were detected by cytokine ELISAs. Splenocytes were 
diluted as per sample cell counts and 4 x 105 cells  were plated per well (in triplicate) in 
sterile NUNC Maxisorb flat-bottomed 96 well plates coated overnight with  anti-CD3 at 
10 µg/well.  Anti-CD28 (10 µg/well) were added to each well and incubated for 48 hours 
at 37°C. Supernatants were harvested and stored at -80°C until required for future 
ELISAs. 
Specificity Dilution Source 
IgA 1:1000 Southern Biotech 
IgG 1:1000 AbD Serotech 
IgG1 1:1000 Southern Biotech 
IgG2b 1:2000 Southern Biotech 
IgG2c 1:1000 Southern Biotech 
IgG3 1:1000 Southern Biotech 
IgM 1:2000 Southern Biotech 
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Table 2.5 Antibodies used for Cytokine ELISAs 
Specificity Clone Dilution Source Application 
Purified CD3e 
(No Azide) 
17A2 1:100 e-Bioscience  
Antibody used 
for Ex-Vivo 
Cytokine Re-
Stimulation 
Purified CD28 
(No Azide) 
JJ319 1:1000 BD Biosciences 
Purified IFN-γ N/A 1:1000 e-Bioscience Capture 
Antibody 
IFN-γ 
Recombinant 
Protein 
N/A 1:2000 e-Bioscience Standard 
Antibody 
Biotinylated IFN- 
γ 
N/A 1:1000 e-Bioscience Detection 
Antibody 
Purified TNF-α N/A 1:4000 e-Bioscience Capture 
Antibody 
TNF-α 
Recombinant 
Protein 
N/A 1:1000 e-Bioscience Standard 
Antibody 
Biotinylated 
TNF-α 
N/A 1:4000 e-Bioscience Detection 
Antibody 
 
NUNC Maxisorp 96-well plates were coated and sealed overnight at 4°C with 100 µL per 
well of capture antibody (IFN-γ and TNF-α ) in 1x Coating Buffer (e-Bioscience) as 
outlined in Table 2.5. Following the overnight incubation, plates were washed five times 
in wash buffer ( as described in Section 2.8.1)(Hoiseth and Stocker, 1981). Plates were 
then blocked with 200 µL of 1x Assay Diluent (eBioscience) and incubated for 1 hour at 
room temperature. After blocking, plates were washed in wash buffer four times. 
Standard antibodies were then diluted in 1x Assay Diluent as per Table 2.5 and 100 µL 
were added to each well. Two-fold serial dilutions were performed on the top standards 
(IFN-γ and TNF-α ). Samples were initially diluted at 1:50 and two-fold serial dilutions 
were subsequently performed. Plates are then sealed and incubated overnight at 4°C. 
Following overnight incubation, plates were washed in wash buffer four times and then 
100 µL of diluted detection antibody (Table 2.5) was added to each well and then sealed 
and incubated at room temperature for 1 hour. Following incubation, plates were 
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washed as described previously and 100 µL of diluted Avidin-HRP enzyme (1:4000) 
(eBioscience) was added to each well and then sealed and incubated for 30 minutes at 
room temperature. Plates were then washed as described previously. 1x TMB Substrate 
solution (eBioscience) (100 µL per well) was then added and incubated for 15 minutes 
at room temperature. Finally, 50 µL of Stop Solution (1M H2SO4) was added to each well. 
The plates were then read at an absorbancy of 450 nm using Softmax Pro software on an 
Emax Precision Microplate Reader (Molecular Devices) and the cytokine titres were 
obtained.   
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2.10 Histology 
2.10.1 Tissue Freezing 
Spleens and thymus tissues were cleaned under a dissecting microscope and then 
weighed and dissected into portions for freezing. One half of the spleen and one lobe of 
the thymus was snap frozen in liquid nitrogen and was stored at -80°C for analysis by 
immunohistochemistry (IHC). 
2.10.2 Sectioning Tissue 
To assess the pathogenicity of STm and subsequent immune response within the spleen 
and thymus, tissues were sectioned on a cryostat (Bright Instruments, Huntington, UK) 
using OCT TissueTek compound (Dako, Denmark).  All sections were cut at a 5 µm 
thickness and mounted onto four-spot slides (CA Hendley Essex Ltd., Essex, UK). 
Sections were left to air-dry for 1 hour before fixation in acetone for 20 minutes at 4°C. 
Slides were air-dried overnight and then stored in polythene bags at -20°C until 
required for immunohistochemistry.  
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2.10.3 Immunohistochemistry (IHC) 
Slides were thawed and re-hydrated in Tris buffer (pH 7.6) (1.0 L 200 mM Tris Base, 1.5 
L 154 mM Physiological NaCl, 1.0L of 0.1 N HCl. Primary antibodies (Table 2.7) were 
diluted in Tris buffer (pH 7.6) and 75 µL of the appropriate antibody was added to each 
spot on the section slides. Sections were incubated for 1 hour at room temperature in a 
moist chamber and then washed twice in Tris buffer (7.6) for 5 minutes. Secondary 
antibodies conjugated with horse-radish peroxidase (HRP) or biotin (Bt) (Table 2.7) 
were pre-adsorbed in 10% normal mouse serum (NMS) and then made up to the correct  
volume in Tris buffer (pH 7.6) prior to addition to the slides. Slides were then incubated 
in a moist chamber for 45 minutes. Goat anti-hamster IgG (heavy and light chains) was 
added to the secondary antibody solution only prior to the addition of the 75 µL 
secondary antibody cocktail to the section only if hamster anti-mouse primary 
antibodies were used in the staining protocol. Following the incubation period, slides 
were washed twice in Tris buffer (pH 7.6) as before.  
Alkaline phosphatase (AP)  (AB Complex, Vector Laboratories, CA, USA)  complex was 
pre-absorbed by the addition of equal amounts of A (avidin) and B (biotinylated AP) at a 
1:100 dilution for 30 minutes. 75 µL was added to slides which were then incubated at 
room temperature for 40 minutes and then washed twice as before in Tris Buffer (pH 
7.6).  
Slides were then developed as follows. One peroxidase substrate , 3,3´-diaminbenzidine 
tetrahydrochloride (DAB) tablet was dissolved in 15 mL of Tris buffer (pH 7.6). The 
substrate was filtered immediately and one drop of hydrogen peroxide was added.  The 
substrate was used immediately by adding one drop to each section. The substrate was  
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left to develop until the desired level of stain intensity was reached. Slides were 
individually washed as before in Tris buffer (pH 7.6).  
Slides were then developed with the AP substrates (napthol AS-MX phosphate and Fast 
Blue BB salt). Levamisole (8 mg) was dissolved in 10 mL Tris buffer (pH 9.2) in order to 
inhibit endogenous phosphate activity. Napthol AS-MX phosphate (4 mg) was dissolved 
in N,N- dimethyl-foramide (380 µL) in a glass bottle in a fume hood.  This solution was 
then added to the middle of the Levamisole [(-) tetramisole hydrochloride] solution in 
order to avoid a reaction with the plastic universal tube. Fast Blue BB salt (10 mg) was 
then added to the solution and then filtered immediately prior to the addition to slides. 
A single drop was added to each section until the desired level of stain intensity was 
reached. Slides were were washed in Tris Buffer (pH 7.6) as before and then washed 
twice in distilled H2O to inhibit any further reaction of the substrates. Slides were then 
left to air-dry overnight and were mounted in the morning using Glycerol Gelatin 
(Sigma).  
Photographs of desired areas of spleen and/or thymus sections were then taken using a 
Leica CTR6000 microscope (Leica, Milton Keynes, UK), QCapture software, and Image J 
for processing.   
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Table 2.6 Antibodies used for Immunohistochemistry 
Antibodies Isotype  Dilution Source 
Primary Antibodies  
B220 Rat anti-mouse 1:200 BD Pharmingen 
CD103 Rat anti-mouse 1:200 BD Pharmingen 
CD11c Hamster anti-mouse 1:500 AbD Serotech 
CD3 Rat anti-mouse 1:500 AbD Serotech 
CD3e Hamster anti-mouse 1:300 BD Pharmingen 
CD4 Rat anti-mouse 1:800 BD Pharmingen 
F4/80 Rat anti-mouse 1:400 AbD Serotech 
IgA Rat anti-mouse 1:200 BD Pharmingen 
IgD Sheep anti-mouse 1:800 AbCam  
IgG Rat anti-mouse 1:300 AbD Serotech 
IgG2b Rat anti-mouse 1:200 BD Pharmingen 
IgG2a Rat anti-mouse 1:250 BD Pharmingen 
IgG3 Rat anti-mouse 1:200 AbD Serotech 
IgM Rat anti-mouse 1:300 AbD Serotech 
IgM HRP-Goat anti-mouse 1:50 Southern Biotech 
PNA Bt-Peanut Agglutinin 1:200 BD Pharmingen 
Secondary Antibodies  
Donkey anti-Sheep 
Peroxidase (Px) 
Donkey anti-sheep 1:300 Jackson Laboratories 
Goat anti-Hamster IgG 
(heavy and light chains) 
Goat anti-hamster 1:100 Southern Biotech 
Rabbit anti-Rat Biotin 
(Bt) 
Rabbit anti-rat 1:600 Dako 
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2.11 Statistical Analysis 
Statistical analyses were performed using GraphPad Prism version 5.  The statistical 
analysis of the results was determined by the Mann-Whitney U non-parametric sum of 
ranks test. A value of  P<  0.05 was considered statistically significant. Experiments were 
repeated with significant findings indicated in the figure legends. 
2.12 Media and Buffers 
LB Agar Plates 
20 g of Granulated Agar (Melford Laboratories, Ipswich, UK) and 20 g of LB Broth 
Base powder (Invitrogen) were dissolved in 1L distilled H2O and autoclaved at 
121°C for 30 minutes. Agar plates were poured in a fume hood whilst the agar was 
still warm and were dried at room temperature for a couple of hours. Plates were 
stored at 4°C until required. 
LB Media 
20 g LB Broth Base powder (Invitrogen, Paisley, UK) was dissolved in 1L distilled 
H2O and autoclaved at 121°C for 30 minutes. The media was cooled down to room 
temperature prior to use.  
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C hapter 3: Results 
3.1 Period of infection 
Mice were infected as described in section(s) 2.3.1.1 and 2.3.2 and sacrificed on days 0,7, 
and 35 post-infection.  These days were chosen in order to characterise the response of  
STm to WT and CD8 KO mice in the spleen, PEC, and thymus during the early (Day 7) 
and late (Day 35) stages of infection.  
3.2 STm infection induces a multi-organ response  
After sacrifice, WT and CD8 KO spleens, thymus, and peritoneal exudate cells (PEC) were 
extracted in order to characterise the extent of STm infection during a systemic NTS 
infection at days 0, 7, and 35 post-infection.  The host mounts a successful immune 
response against STm infection within the first week; however, it is not effective in 
establishing sterile immunity. Subsequently, the adaptive immune response is 
established by days 18-21 and resolution should occur by day 35 post-infection. Initially, 
we set out to investigate the role of CD8 loss in the thymus during systemic Salmonella 
infection; however, we found that it contributed to a multi-organ response in other areas 
such as the spleen and peritoneal cavity. 
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3.3 The Spleen 
3.3.1 Splenomegaly is induced within the host and severely disrupts the architecture 
of the spleen during the course of STm infection. 
Splenomegaly was observed within the host at day 7 in both WT and CD8 KO (Figure 
3.1a) and decreased in both groups of mice at day 35 (Figure 3.1b). This is equally 
correlated with the levels of bacterial burden within the tissue (Figure 3.2). However, 
the bacterial burdens within CD8 KO mice at day 35 post-infection are still elevated in 
contrast to WT mice (Figure 3.2a)(*,P=0.0286) .   
Splenomegaly severely disrupts the architecture of the spleen in both WT and CD8 KO 
mice (Figure 3.3). At day 0, the white pulp (WP) and red pulp (RP) are clearly defined, 
along with the MZ, B-cell follicles, and T-zone areas. By day 7, there is a distinct lack of 
organization within the spleen. The MZ has disappeared and there is a loss of distinction 
between the red pulp and the white pulp.  By day 35, GCs appear and are present within 
the spleen.  
 
 
 
 
41 
 
 
 
Spleen Mass
WT
 
Da
y 0
CD
8 K
O D
ay
 
0
WT
 
Da
y 7
CD
8 K
O D
ay
 
7
WT
 
Da
y 3
5
CD
8 K
O D
ay
 
35
0.0
0.2
0.4
0.6
0.8
Days post-infection
Sp
le
en
 
M
as
s 
(g
)
WT
 
Da
y 0
WT
 
Da
y 7
WT
 
Da
y 3
5
0.0
0.2
0.4
0.6
0.8
Spleen Mass WT
Days post-infection
Sp
le
en
 
M
as
s 
(g
)
CD
8 K
O D
ay
 
0
CD
8 K
O D
ay
 
7
CD
8 K
O D
ay
 
35
0.0
0.2
0.4
0.6
0.8
Days post-infection
Spleen Mass CD8 KO
Sp
le
en
 
M
as
s 
(g
)
A.
B. C.
* *
* *
*
 Figure 3.1 Changes in splenic mass occur over the course of STm infection. (A) Splenomegaly was 
observed by day 7 post-infection in both WT and CD8 KO mice and decreased as resolution of STm 
infection occurred. (B) Spleen mass of WT mice (C) Spleen mass of CD8 KO mice. Data is taken from one 
experiment where n=4. The Mann-Whitney U test was used to confirm statistical significance. Data 
represented as mean +SEM. * represents statistically significant data (P<0.05) 
 
 
42 
 
Bacterial Burden
WT
 
Da
y 7
CD
8 K
O D
ay
 
7
WT
 
Da
y 3
5
CD
8 K
O D
ay
 
35
1.0×101
1.0×102
1.0×103
1.0×104
1.0×105
Days post-infection
CF
U 
pe
r 
Sp
le
en
WT
 
Da
y 7
WT
 
Da
y 3
5
1.0×101
1.0×102
1.0×103
1.0×104
1.0×105 *
Bacterial Burden
Days post-infection
CF
U 
pe
r 
Sp
le
en
CD
8 K
O D
ay
 
7 
CD
8 K
O D
ay
 
35
1.0×102
1.0×103
1.0×104
1.0×105
Days post-infection
*
Bacterial Burden
CF
U 
pe
r 
Sp
le
en
Figure 3.2. Bacterial burdens are highest at day 7 post -infection and decrease by day 35 post -
infection.  Bacterial burdens are directly proportional to spleen weights during the first week of STm 
infection. (A) Comparison of bacterial burden between WT and CD8 KO mice at days 7 and 35 post -
infection. (B) WT bacterial burden at days 7 and 35 post -infection. (C) CD8 KO bacterial burden at 
days 7 and 35 post -infection. Data is taken from one experiment where n=4 , except for the CD8 KO 
mice group at day 0 wh ere n=6. The Mann-Whitney U test was used to confirm statistical 
significance. Horizontal bars represent means . * represents statistically significant data (P<0.05) . 
*
A. B.
C.
 
43 
 
 
 
A
.  
B
 
C
 
D
 
E
 
F
 
D
a
y
 0
 
D
a
y
 7
  
D
a
y
 3
5
 
F
ig
u
re
 3
.3
 I
m
m
u
n
o
h
is
to
ch
e
m
is
tr
y
 s
ta
in
in
g
 f
o
r 
F
4
/8
0
 (
b
lu
e
) 
a
n
d
 I
g
D
 (
b
ro
w
n
) 
 d
u
ri
n
g
 d
a
y
s 
0
,7
, 
a
n
d
 3
5
 p
o
st
-S
Tm
 i
n
fe
ct
io
n
 
(A
,B
,D
,E
-X
1
0
 i
m
a
g
e
)(
C
,F
-X
2
0
 i
m
a
g
e
) 
(A
-C
) 
W
T
 m
ic
e
 (
D
-F
) 
C
D
8
 K
O
 m
ic
e
. 
B
lu
e
 a
re
a
s=
 r
e
d
 p
u
lp
 (
R
P
),
 b
ro
w
n
 a
re
a
s=
 w
h
it
e
 
p
u
lp
 (
W
P
),
 G
C
s 
a
re
 a
b
se
n
t 
in
 d
a
ys
 0
 a
n
d
 7
, 
b
u
t 
a
re
 p
re
se
n
t 
a
t 
d
a
y
 3
5
. 
 
G
C
 
R
P
 
W
P
 
F
 
44 
 
3.3.2 Flow cytometric analysis  
3.3.2.1 Splenic T-cell populations 
In addition to visualizing the spleen via IHC, there were no significant differences seen 
between WT and CD8 KO mice in the number of CD4+T-cells, CD3+CD4+T-cells, effector 
cells (CD620loCD44hi), and naïve cells (CD62hiCD44lo) (Figure 3.4). However, one can 
still detect subtle increases in the expanded T-cell populations from day 0 to day 7 , as 
depicted in Figure 3.4. 
3.3.2.2 Splenic B-cell populations 
Splenic B-cell populations were also assessed for their distinct phenotypes. Follicular, 
MZ, and transitional populations were gated on B220+ and IgM+. There were no 
apparent differences seen between WT and CD8 KO follicular and MZ B-cell populations 
gated on B220+ and IgM+ (Figure 3.5). However, there were statistically significant 
differences seen between WT and CD8 KO transitional B-cell populations gated on B220+ 
(*,P=0.0381) and IgM+ (*, P=0.0381) at day 0.  
3.3.2.3 Splenic plasma cell populations 
Splenic plasma cell populations were also assessed for an IgG2b+ or IgG2c+ phenotype. 
These populations were gated on B220intCD19intCD138+ and CD138+, respectively. 
There were no statistically significant differences seen between WT and CD8 KO plasma 
cell populations (Figure 3.6).  
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3.3.3 Antigen-specific antibodies can be detected by ELISAs and 
immunohistochemistry (IHC) within the spleen 
Serum IgM and IgG were detected by ELISAs against outer membrane proteins (OMPs) 
and this could be visualised by immunohistochemistry (IHC).  Lower levels of OMP-
specific IgG antibody were detected in the spleens of CD8 KO mice (Figure 3.7b) in 
contrast to WT (Figure 3.7a)  on day 7 post-infection and this was quantified by ELISA 
(Figure 3.7c) (*,P=0.0270). Normal levels of OMP-specific IgM antibody were detected in 
both WT and CD8 KO mice, which was visualised by IHC (Figure 3.8a/b) and quantified 
by ELISA (Figure 3.9c) at day 7 post-infection and persisted at day 35 during STm 
infection. The lower levels of IgG did not persist within the CD8 KO mice and levels 
returned to normal at approximately day 35 (Figure 3.9) (pictures not shown).   
Furthermore, serum IgG2b+ and IgG2c+ antibody can be detected via ELISAs and IHC 
(Figure 3.10 and 3.11, respectively). Lower levels of IgG2b antibody were detected in the 
spleens of CD8 KO mice by ELISA (*,P=0.0210)  (Figure 3.10g) and can be visualised by 
IHC, particularly at day 7 post-infection ( Figure 3.10d). However, IgG2b antibody titres 
were seen to increase substantially in both WT and CD8 KO mice from day 0 to day 7 
post-infection (data not shown).  IgG2b antibodies were also seen at day 35 post-
infection (Figure 3.10e and 3.10f). However, there were no differences found in the 
levels of IgG2c antibody titres by ELISA (P=0.0627), but there seems to be a lower trend 
in the quantity of IgG2c antibody in CD8 KO mice (Figure 3.11c). However, this was quite 
difficult to visualize by IHC and no significant differences were seen by staining (Figure 
3.11a and 3.11b).  
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Figure 3.9. Relative antibody titres of OMP-specific IgG (A) and IgM (B) in WT
and CD8 KO mice post-infection with STm. Serum anti-OMPs antibody titres were
quantified by  ELISA. Data is representative of 4 mice per group in both A and B apart
from Day 7 WT and CD8 KO mice in (A), which reflects 3 independent experiments.
Horizontal bars reflect means. *P< 0.05.
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Figure 3.10. Differences in the antigen-
specific IgG2b antibody response can be  
detected in the spleen via IHC (x10 
images-A –D) (x20 images E-F)  and 
ELISAs (Day 7) (G).  IgG2b antibody levels 
were visualised by IHC  in WT and CD8 KO 
mice, respectively on day 0  (A-B), day 7 
(C-D), and day 35 (E-F). Serum IgG 2b 
titres (G) were assessed from WT (C) and 
CD8 KO (D) mice by ELISA against OMPs. 
Horizontal bars represent means. Data is 
representative of three-independent 
experiments and 4 mice per group. 
*P<0.05. The Mann-Whitney U test was 
used to compare the statistical 
significance between groups . 
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3.4 The Peritoneal Cavity  
The peritoneal cavity was assessed for B1b cells. There were no significant differences seen 
between WT and CD8 KO mice on days 7 and 35; however, there was a significant difference 
found on day 0 (*,P=0.0190) (Figure 3.12).  
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Figure 3.12.  B1b cells within the peritoneal cavity.  Data is taken from one experiment
where n=4. The Mann-Whitney U test was used to confirm statistical significance.
Horizontal bars represent means. * represents statistically significant data (P<0.05).
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3.5 The Thymus 
3.5.1 Thymic atrophy is induced over the course of STm infection 
Thymic atrophy is induced over the course of STm infection and is reflected by its mass 
size at day 7 post-infection in both WT and CD8 KO mice (Figure 3.13). There were no 
significant differences in thymic mass nor bacterial burden (Figure 3.14) between both 
groups , thus, bacterial culture was not performed on the thymus at day 35 post-
infection.  
3.5.2 Thymic DCs  
Thymic DCs play an integral role in the uptake and presentation of STm i.e. the MLN 
before migrating to the thymus (Voedisch et al., 2009). In the periphery, DCs that reside 
in the intestinal epithelium are known to internalise STm and then infect macrophages 
in the submucosa (Ibarra and Steele-Mortimer, 2009). Thus, IHC was performed to 
visualise thymic macrophages (F4/80+CD11c+) (Figure 3.15), pDCs (Figure 3.16) , and 
CD103+DCs (Figure 3.17).  
Thymic DCs were very rare and difficult to visualise with IHC, thus, there were no 
differences found in the number nor type of DCs in WT and CD8 KO mice.  
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Figure 3.13. Changes in thymic mass occur over the course of STm infection. (A) Thymic atrophy was 
observed by day 7 post-infection in both WT and CD8 KO mice and resolved as bacterial clearance was 
enhanced by day 35. (B) Thymic mass of WT mice (C) Thymic mass of CD8 KO mice. Data is taken from one 
experiment where n=4. The Mann-Whitney U test was used to confirm statistical significance. Data 
represented as mean +SEM. * represents statistically significant data (P<0.05).  
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Figure 3.14.  At day 7 post-infection, thymic atrophy is observed, but bacterial burden is similar in WT and 
CD8 KO mice. (A) Thymic atrophy was observed by day 7 post-infection in both WT and CD8 KO mice  (B) 
Bacterial burden of the thymus is similar in WT and CD8 KO mice at day 7 post-infection. Data is taken from 
one experiment where n=4. The Mann-Whitney U test was used to confirm statistical significance. Data 
represented as mean +SEM. * represents statistically significant data (P<0.05).  
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A B 
C D 
E F 
Figure 3.15. IHC staining for F4/80
+
(blue) and CD11c (brown) thymic macrophages at the 
corticomedullary junction . Thymus sections were taken from WT and CD8 KO mice, respectively at 
days 0 (A and B), 7 (C and D), and 35 (E and F) post-infection.  (A and B are x10 images) (C-F are x20 
images).  
Medulla Cortex 
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A. B. 
C. D. 
E. F. 
Figure 3.16. IHC staining for B220
+ 
(blue) and CD11c
+
 (brown) plasmacytoid DCs (pDCs) (x10 
magnification) . Thymus sections were taken from WT and CD8 KO mice, respectively at days 0 (A and 
B), 7 (C and D), and 35 (E and F) post-infection.   
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A.  
B. 
 
Figure 3.17. IHC staining for CD103 (blue) and 
CD11c (brown) (x10 magnification) . Thymus 
sections were taken from WT and CD8 KO mice, 
respectively at days 7 (A and B) post-infection.  
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Chapter 4: Discussion 
4.1 A role for CD8 in the primary response to STm infection 
Prior to this study, it has been evidenced that the lack of CD8 molecules does not impact 
the MHC Class II restricted helper T-cell response in STm infection (Fung-Leung et al., 
1991). Although there were no statistically significant differences within the splenic T-
cell populations in WT and CD8KO mice, CD8 KO mice did not effectively clear bacteria 
as well as WT mice at day 35 post-infection within the spleen. However, this was not 
reflected in the splenic masses as there was no additional evidence of increased 
splenomegaly at day 35 within CD8 KO mice. Splenic masses and bacterial burden 
should decrease by day 35 in both WT and CD8 KO mice during STm infection as 
evidenced by Jackson et al. (2010).  Thus, these experiments would need to be repeated 
at day 35 in order to determine splenic masses and bacterial loads in CD8 KO mice. This 
suggests that CD8+T-cells may play a minor role in establishing bacterial clearance 
during primary infection. Previous studies have shown that CD8-deficient mice that have 
been challenged with an attenuated strain of STm only show a mild deficiency in 
effectively clearing STm (Moon and McSorley, 2009). 
Also, CD8+T-cells have played a role in bacterial clearance at the latter stages of 
attenuated STm infection in conjunction with perforin and granzyme B, which are both 
proteins that provide for the cytolytic nature of CD8+CTLs (Lee et al., 2012). Lee et al. 
(2012) has hypothesized that CD8+CTLs may play a synergistic role in the primary 
stages of STm infection with regards to the release and presentation of STm antigens to 
MHC class-II restricted CD4+T-cells. This hypothesis can be confirmed by the fact that 
CD8+T-cells respond to T-helper 2 (Th2) presented antigens and induce Th1 cytokines, 
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which in turn enhances the proliferation and differentiation of B-cells and CD4+T-cells, 
which are extremely important in mounting an immune response against STm (Mohr et 
al., 2010).  
This may be correlated with the lower levels of OMP-specific IgG antibody titres seen at 
day 7 post-infection in CD8 KO mice.  
IgG is the most abundant antibody present in the immune response against STm (Goh et 
al., 2011). Previously, it has been shown to confer protection against secondary virulent 
STm infections in mice (Goh et al., 2011).  Furthermore,  four subclasses of IgG exist 
within the murine model and their flexibility is characterised as follows: 
IgG2b>IgG2a>IgG3>IgG1 (Roux et al., 1997).  
IgG, IgG2b, and IgG2a (trend) (IgG2c in C57BL/6 mice (Martin et al., 1998)) antibody 
responses to OMPs were found to be significantly lower in CD8 KO mice. Please note that 
WT and CD8 KO mice were immunised with purified porins in preliminary experiments 
to characterise the antibody-mediated response to STm infection; however, only two 
mice appeared to be protected once challenged with STm. It was difficult to assess 
whether or not the porins or STm were administered successfully by i.p. injection. Thus, 
we decided not to pursue these experiments (data is not shown).  
It has been evidenced that T-dependent switching to IgG2b and IgG2a (IgG2c) reflects an 
early, extrafollicular (EF), Th1-mediated response within the first three weeks of STm 
infection (Cunningham et al., 2007). They also contribute to memory B-cell responses to 
STm (Secundino et al., 2006). Furthermore, it was evidenced by Cunningham et al. 
(2007) that IgG2c antibody responses to OMPs could be detected by day 7 post-infection 
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in WT mice and that OMPs were major targets of early, switched IgG2c antibody 
responses.   Therefore, the EF response is integral in mediating bacteraemia and can 
protect against subsequent STm infections (Cunningham et al., 2007).  
Clearly, the higher bacterial burdens at day 35 and the lower levels of OMP-specific IgG 
at day 7 post-infection suggest a defect in the early EF response to STm. Thus, the 
absence of CD8 molecules must impact the early TFH response during thymus-dependent 
(TD) antibody responses.  TFH cells induce the production of IFN-γ, which is known to 
mediate bacterial clearance, as well as isotype class switching.  
 Previously, it has been  shown that STm infections induce a strong EF plasma cell 
response, which produces IgM (TI response) and IgG class-switching of B-cells to IgG2a 
(IgG2c in C57BL/6 mice) and IgG2b (TD response) (Lee et al., 2011). This is evidenced 
here in this investigation with regards to WT mice, but is absent in CD8 KO mice.  
CD8+T-cells when primed by alum-precipitated proteins have been shown to produce 
IFN-γ (Mohr et al., 2010).  Additionally, STm-specific CD8+T-cells primed with alum-
precipitated proteins can contribute to antibody class switching from IgG1 (Th2) to 
IgG2a (IgG2c in C57BL/6 mice) and IgG2b (Th1). It is unclear how CD8+T-cells affect 
class-switching in B-cell follicles in the spleen since these cells aren’t found there; 
however, they produce IFN-γ, which leads to the migration of Th1 cells to germinal 
centres in the spleen (Mohr et al., 2010). Furthermore, Mohr et al. (2010) has shown 
that ovalbumin-specific CD8+T-cells (OTI) may indirectly induce class-switching from 
the outer T-zone located in the white pulp of the spleen.  
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In a recent study, it was found that IgG allows DCs to process and present antigen 
efficiently to T-cells once challenged with STm (Riquelme et al., 2012).  The presence of 
IgG within immune complexes initiates the phagocytosis of antigens (Riquelme et al., 
2012). The mechanism behind this phenomenon could be due to the suppression of the 
release of SP1-1 (Salmonella Pathogenicity Island-1) derived effectors that inhibit DC-
mediated phagocytosis of STm (Riquelme et al., 2012). Furthermore, the event of IgG2a 
(IgG2c) isotype being bound to FcγRI allows for the phagocytosis of pathogens via 
enhancing the production of reactive oxygen intermediates (Goh et al., 2011).  
Lower relative titres of IgG antibody may inhibit bacterial clearance in mice during the 
primary immune response. This hypothesis is concurrent within the results from this 
study where CD8 KO mice had higher bacterial burdens in contrast to WT mice at day 35 
post-infection. This suggests that the lower levels of IgG at day 7 post-infection inhibit 
bacterial clearance later on in STm infection, even though IgG titres return to normal 
levels at day 35 post-infection. 
 Interestingly, this phenomenon challenges the results from previous studies that 
suggest that CD8-deficient mice are not inhibited in resolving primary STm infection 
with an attenuated strain of STm (Ravindran and McSorley, 2005).  
However, it has been suggested IgG antibody responses may contribute more to the 
inhibition of STm-specific responses that inhibit DC priming of naïve T-cells rather than 
bacterial clearance (Ravindran and McSorley, 2005).  
Splenic B-cell transitional WT and CD8 KO populations gated on B220+ and IgM+ at day 0 
were statistically different from one another. The small differences in baseline 
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transitional B-cell numbers could be due to various reasons, which weren’t pursued in 
this investigation. However, it can be hypothesised that the absence of CD8+T-cells in 
CD8 KO mice may contribute to their niche being occupied by more transitional B-cells 
as there isn’t an increase in CD4+T-cell numbers seen at day 0.  
Please note that PBS controls were included in experiments on Days 7 and 35 post-
infection; however, they were not included in experiments on Day 0 in order to avoid 
unnecessary physiological stress to the mice immediately before they were sacrificed. If 
the mice were immediately sacrificed after injection, this stress may have been reflected 
in the results such as the quantification of splenic T and B-cell populations.  
DC populations in the thymus were visualised via IHC staining; however, they were not 
assessed by IHC in the spleen nor flow cytometry (thymus only). There were no 
detectable differences between F4/80+CD11c+ thymic macrophages, B220+CD11c+ 
plasmacytoid cells, nor CD103+CD11c+ dendritic cells in WT and CD8 KO mice. In fact, 
these dendritic cell populations were quite rare in the thymus.  Furthermore, the thymic 
mass and bacterial burden did not differ between WT and CD8 KO mice. Thus, it was 
difficult to assess the relationship between IgG and DC priming of naïve T-cells. 
It has been documented that studies using attenuated strains of STm have  lower 
invasion and intracellular replication rates (Lo et al., 1999). Therefore, these types of 
infections could induce a weak CD8+CTL response, which is non-reflective of infection 
with a virulent strain of STm (Lo et al., 1999). Furthermore, other studies have shown 
that vaccine-induced protection once challenged with virulent strains of STm is 
significantly reduced (Mittrucker et al., 2002).  
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More importantly, a study has shown that CD8+T-cell programming for differentiation, 
proliferation, and contraction is dependent on host-interactions with STm (Luu et al., 
2006). Their model evidenced that the presentation of STm antigens to CD8+T-cells 
occurs within the first few days of infection and peaks at day 7 of the infection (Luu et 
al., 2006). In fact, different strains of STm may affect the differentiation of CD8+T-cells 
due to differences in the genetic background of the host, route of infection, infectious 
dose, degree of host inflammation, growth rate, and intracellular location (Luu et al., 
2006, Mastroeni and Sheppard, 2004). 
Furthermore, studies have suggested that intravenous (IV) and intraperitoneal (IP) 
routes of infection, as well as using attenuated strains of STm have led to inconsistent 
results (Hughes and Galan, 2002).  
4.2 Future work 
With regards to my immediate future plans, I would increase the sample size and repeat 
experiments, particularly at day 7 post-infection, in order to achieve a more robust 
statistical analysis. Furthermore, I would repeat experiments at day 35 in order to 
investigate the differences in splenic bacterial burden seen between WT and CD8 KO 
mice. Additionally, if there was still evidence of an increased bacterial load at day 35 in 
CD8 KO mice and no statistical difference in their splenic masses from day 7 to day 35, 
then I would carry out and investigate the correlation between the increased bacterial 
burden and the lack of additional splenomegaly. 
I would like to investigate a few areas in the future due to the defect in the early TFH 
response at day 7and the reduced bacterial clearance at day 35 post-infection in CD8 KO 
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mice. It would be interesting to challenge CD8 KO mice with a virulent strain of STm, 
such as SL1344, to see if previous infection with the attenuated strain of STm, SL3261, 
confers cross-protection via bacterial clearance and/or an antibody-mediated response.  
Furthermore, it would be interesting to deliver STm-specific IgG to CD8 KO mice in 
order to mount an IgG antibody-mediated response at day 7 post-challenge with STm. 
Furthermore, STm-specific IgG may significantly reduce bacterial titres once challenged 
with STm at day 35 post-infection in CD8 KO mice.  
Additionally, I would employ confocal microscopy and flow cytometry techniques in 
order to visualize and quantify DC numbers in the thymus as they were very rare and 
difficult to visualise by IHC.  
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